Greencamp

DECEMBER 4, 2018

This reaction is dependent on the type of cell that was activated through these receptors, but also on the condition our body is struggling with. The way a specific cell reacts when a cannabinoid activates its receptor is also dependent on the type of condition that an organism is afflicted with. Endocannabinoid system discovery.

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Refractory paediatric epilepsy. Spasticity from neurological conditions.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

FEBRUARY 1, 2020

In the past decade, Australian support for medical marijuana has increased continuously, rising from 69% in 2013 to 85% in 2016 , when the growth & cultivation of cannabis for medical and scientific purposes finally became legal. in 2013 to 14.5% Medical Use & Cannabis Research. Nonetheless, the violence had a strong impact.

Legalization 59

Legalization Research and Development Recreational Access 59

Cannabis Law Report

JULY 12, 2019

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Lancet Neurol Dec 23 2015.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73